InternationalUSRemember you can easily switch between MIP US and MIP International at any time

About us

Founded in 1990, Managing IP is the leading source of news and analysis on all intellectual property developments worldwide. Features include: news on major cases, deals and legislation; analysis of strategies and trends; data; interviews and profiles of leading figures in IP; surveys of leading IP firms; and case studies.

Many parts of managingip.com, including the daily blog, country supplements, conference newspapers and international briefings, are freely accessible. Managing IP subscribers have full access to the entire website, including in-depth news, analysis and surveys, and the archive going back to 1999.

Take a trial and sign up to receive the MIP newsletters





For information on advertising with Managing IP contact:

Managing IP also has a Chinese-language website at www.managingip.cn. The IP Handbook, now in its 19th edition, can be viewed and searched at www.miphandbook.com.

Managing IP is part of the Euromoney Legal Media Group. Other publications in the group include International Financial Law Review, China Law and Practice, International Tax Review and Transfer Pricing Week.

Euromoney Institutional Investor PLC is listed on the London Stock Exchange. For more information: www.euromoneyplc.com.

profile

Managing IP

ManagingIP

ManagingIP profile

RT @mdloney: SCOTUS TC Heartland v Kraft Foods Group Brands oral argument transcript is up! https://t.co/v29vEKCILp

Mar 27 2017 07:50 ·  reply ·  retweet ·  favourite
ManagingIP profile

Likely to be an important question for some applicants, with UPC due to come into force in December this year https://t.co/ASuSYUpRqd

Mar 27 2017 04:40 ·  reply ·  retweet ·  favourite
ManagingIP profile

Don't forget to sign up for our next webinar, on IP in Asia, this Thursday at 3pm (London) https://t.co/gh3Ka8t9q1 @inoviaIP @Minesoftnews

Mar 27 2017 04:38 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


March 2017

Roundtable: The second medical use challenge – full transcript

Three leading patent specialists discussed one of the most challenging issues in IP at the moment – incentivising new uses for known drugs – at a recent roundtable discussion. The participants were: Jurgen Dressel, head of global patent litigation strategy, Novartis Pharma; Galit Gonen, VP and general counsel for Europe at Teva; and Professor Sir Robin Jacob, former Court of Appeal judge and professor at the Institute of Brand and Innovation Law, University College London



Most read articles

Supplements